| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
neurofilament light | 0.488 | 0.769 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1996 | 1996 | |||||||||
|
transient receptor potential cation channel subfamily M member 2 | 0.546 | 0.731 | 9.0E-44 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
von Willebrand factor | 0.408 | 0.885 | 3.2E-25 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2012 | 2019 | ||||||||
|
WNK lysine deficient protein kinase 4 | 0.644 | 0.538 | 6.9E-25 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ERCC excision repair 6, chromatin remodeling factor | 0.507 | 0.808 | 5.2E-22 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
optineurin | 0.548 | 0.808 | 5.9E-18 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.220 | None | 1.000 | 3 | 0 | 2001 | 2017 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
MAP kinase activating death domain | 0.644 | 0.538 | 1.5E-14 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
protein phosphatase 1 regulatory subunit 15A | 0.608 | 0.692 | 2.2E-12 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
neurofilament heavy | 0.588 | 0.769 | 2.7E-12 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
8-oxoguanine DNA glycosylase | 0.453 | 0.808 | 3.9E-12 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
uncoupling protein 2 | 0.493 | 0.808 | 1.5E-10 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
NAD(P)H quinone dehydrogenase 1 | 0.434 | 0.885 | 1.2E-09 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2017 | 2017 | ||||||||
|
latent transforming growth factor beta binding protein 1 | 0.670 | 0.500 | 3.7E-09 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
gap junction protein beta 6 | 0.528 | 0.808 | 1.7E-07 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
heat shock protein family B (small) member 1 | 0.436 | 0.808 | 2.8E-07 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
transient receptor potential cation channel subfamily C member 6 | 0.514 | 0.692 | 3.0E-07 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2010 | 2013 | ||||||||
|
glutaredoxin | 0.619 | 0.577 | 5.7E-07 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2017 | 2018 | ||||||||
|
glutathione-disulfide reductase | 0.494 | 0.846 | 1.3E-06 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 4 | 0.582 | 0.692 | 2.0E-06 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 |